In recent years, research in the field of dementia has been exploring the role of Nrf2 in the body and uncovering its potential for antioxidant, anti-inflammatory, and mitochondrial functions.[i] Of particular interest is its role in the central nervous system (CNS) and on the aging brain. The following is a roundup of the most current knowledge about Nrf2 and its role in prominent degenerative conditions.
Read More
Times have changed. It’s no longer sufficient to have a promising new drug to test and a relationship with an academic research hospital to get your study off the ground. You need a state-of-the-art Phase I unit with enhanced precautions to ensure the efficacy of your study and safety of patients.
Read More
In his recent webinar, Tomislav Babic discusses the important role of investigators in informing and advising newly diagnosed Parkinson’s disease patients about their treatment and clinical trial participation options.
Read More
A discussion of the patient perspective and how it contributes to a feasible and robust rare disease protocol.
Read More
The following blog provides insights on how to bring patient centricity to study recruitment. This blog is coauthored by experts at Worldwide Clinical Trials and PatientWing.
Read More
The following blog is a high-level overview of special considerations specific to clinical trials addressing COVID-19.
Read More
